HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty Projects Higher Costs For P&G Deal, Orphan Brand Challenges

This article was originally published in The Rose Sheet

Executive Summary

Costs associated with integrating 41 P&G beauty brands are estimated to reach $1.2bn over the next four years, more than doubling Coty's projections when the mega-deal was announced last year, and investments will be needed to galvanize the currently under-supported orphan assets. However, Coty is projecting $780m in synergies and room for further growth as a $9bn beauty force to be reckoned with.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel